Company profile: Currie Medical
1.1 - Company Overview
Company description
- Provider of pneumatic compression devices and garments for DVT prevention, including the ALP DVT Prevention System and VasQcare home-based DVT/PE therapy; ReCur reprocessing services for collection of single-use devices; fluid warming drapes and systems; biohazard spill kits; and medical waste solidifiers to support safety, cost savings, and environmental impact reduction.
Products and services
- ALP DVT Prevention System: Non-invasive external intermittent pneumatic compression system engineered to reduce the incidence of Deep Vein Thrombosis using pneumatic compression pumps and breathable garments
- ReCur Reprocessing Services: Single-use device reprocessing program that collects and reprocesses DVT compression sleeves and other devices to cut costs and lessen environmental impact for healthcare facilities
- VasQcare: Home-based DVT/PE prevention system delivering acute care therapy with a rapid compression cycle to enhance blood circulation and reduce the risk of venous thromboembolism
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Currie Medical
Cordis
HQ: United States
Website
- Description: Provider of less invasive treatments for vascular disease as a Johnson & Johnson company, and developer/manufacturer of stents, catheters, and guidewires. Offerings include SELUTION SLR Drug-Eluting Balloon for controlled, sustained sirolimus release; BRITE TIP Guiding Catheter; MYNX CONTROL Vascular Closure Device; RAIN Sheath Transradial thin-walled introducer; and RAILWAY Sheathless Access System.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cordis company profile →
Medos Medizintechnik
HQ: Germany
Website
- Description: Provider of medical devices for cardiac surgery, extracorporeal membrane oxygenation, and ventricle assist devices, offering VAD cannulae, X-Flow, DELTASTREAM, HILITE, HILITE Reservoirs, and tubing sets (machine-sets, table-sets).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medos Medizintechnik company profile →
Retia Medical
HQ: United States
Website
- Description: Provider of patient monitoring software and hardware, notably the Argos Cardiac Output Monitor using a proprietary Multi-Beat Analysis algorithm for accurate, real-time cardiac output and comprehensive hemodynamic data. Offers quick setup via a single reusable cable, compatibility with arterial lines and multi-parameter monitors, integration with 40+ EMRs, and demonstrated reductions in complications and ICU stay.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Retia Medical company profile →
CoreValve
HQ: United States
Website
- Description: Provider of minimally invasive, catheter-based aortic valve replacement technology enabling the replacement of failing aortic heart valves without surgical access.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CoreValve company profile →
NitroMed
HQ: United States
Website
- Description: Provider of proprietary nitric oxide-based pharmaceuticals, leveraging substantial expertise and intellectual property in nitric oxide drug development. The company discovers, develops, and seeks to commercialize therapies based on the therapeutic benefits of nitric oxide and is conducting a late-stage confirmatory trial of its lead nitric oxide-enhancing drug, BiDil.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NitroMed company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Currie Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Currie Medical
2.2 - Growth funds investing in similar companies to Currie Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Currie Medical
4.2 - Public trading comparable groups for Currie Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →